Reports for IRBESARTAN

Ingredient

IRBESARTAN

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AVALIDE 12.5MG 150MG TABLET Resolved 2018-12-20 2019-02-27 70230
AVALIDE 12.5MG 150MG TABLET Resolved 2019-10-09 2020-01-24 95800
AVALIDE 150MG 12.5MG TABLET Resolved 2021-01-28 2021-03-20 132678
AVALIDE 12.5MG 300MG TABLET Resolved 2019-02-08 2019-03-02 75166
AVALIDE 12.5MG 300MG TABLET Resolved 2019-05-08 2019-05-10 83440
AVALIDE 12.5MG 300MG TABLET Resolved 2019-07-16 2020-01-24 89482
AVALIDE 12.5MG 300MG TABLET Avoided shortage 2022-04-14 2022-08-11 158890
AVALIDE 12.5MG 300MG TABLET Resolved 2022-08-11 2022-08-11 166530
AVAPRO 75MG TABLET Resolved 2018-11-29 2019-02-27 68058
AVAPRO 75MG TABLET Resolved 2019-07-12 2019-11-05 89212

Showing 21 to 30 of 245

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT IRBESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65068
ACT IRBESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65071
ACT IRBESARTAN/HCT Discontinued 2018-10-19 2018-10-19 65074
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760

Showing 1 to 10 of 25